IFNG and neoplasm: Given that ICBs immunotherapy promotes the secretion of IFN-γ, TNF-α and other inflammatory cytokines in tumor microenvironment (WU et al. 2022; ZHANG et al. 2020), we first assessed the influence of cytokines IFN-γ and TNF-α on the expression of CD73 in tumor cells.